Bad drugs from India: Report
As part of the team’s study 360 unexpired samples were collected from 60 medical providers and tested for chemical analysis content, they found that 37 of the samples or 10.3 per cent failed the test.
Most of the 37 samples that failed the test were made in India according to the confidential report. The remaining failed samples came from China (4) and Indonesia (1). The 37 failed samples originated from nine different manufacturers, comprising five from India, three from China and one from Indonesia.
The National Department of Health Secretary Pascoe Kase yesterday said the report was for internal consumption by its malaria program and should not distributed publicly.
"The report of findings from the study of the quality of medicines has given us the evidence we need to advocate for increase resources to ensure our people are being treated with quality medicines," he said in a statement yesterday.
PNG Today/Post Courier
Post a Comment